Literature DB >> 22395801

Outcomes of adrenalectomy in patients with unilateral primary aldosteronism: a review.

O Steichen1, F Zinzindohoué, P-F Plouin, L Amar.   

Abstract

Aldosterone hypersecretion in primary aldosteronism is unilateral (aldosterone producing adenoma and primary unilateral hyperplasia) or bilateral (idiopathic adrenal hyperplasia). Laparoscopic adrenalectomy is nowadays the preferred approach to treat patients with unilateral primary aldosteronism. We review the outcomes of this intervention in recently published series. Laparoscopic adrenalectomy has a morbidity of 5-14%, mortality below 1%, and a mean hospital stay around 3 days. It generally results in the normalization of aldosterone secretion and in a large decrease of blood pressure and antihypertensive medication, but normotension without treatment is only achieved in 42% of all cases. Normotension following adrenalectomy is more likely in young and lean women with recent low grade hypertension than in obese men with long-standing high grade hypertension or a family history of hypertension. However, individual prediction of the blood pressure outcome is not accurate and predictors of hypertension cure should not be used to select patients for surgery. Age, associated health conditions and preferences of the patient are more relevant to this end. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2012        PMID: 22395801     DOI: 10.1055/s-0031-1299681

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  26 in total

1.  Development of novel nomograms to predict renal functional outcomes after laparoscopic adrenalectomy in patients with primary aldosteronism.

Authors:  Takanobu Utsumi; Naoto Kamiya; Mayuko Kaga; Takumi Endo; Masashi Yano; Shuichi Kamijima; Koji Kawamura; Takashi Imamoto; Tomohiko Ichikawa; Hiroyoshi Suzuki
Journal:  World J Urol       Date:  2017-04-11       Impact factor: 4.226

2.  Refining the Definitions of Biochemical and Clinical Cure for Primary Aldosteronism Using the Primary Aldosteronism Surgical Outcome (PASO) Classification System.

Authors:  B S Miller; A F Turcu; A T Nanba; D T Hughes; M S Cohen; P G Gauger; R J Auchus
Journal:  World J Surg       Date:  2018-02       Impact factor: 3.352

Review 3.  Steroid Profiling and Immunohistochemistry for Subtyping and Outcome Prediction in Primary Aldosteronism-a Review.

Authors:  Finn Holler; Daniel A Heinrich; Christian Adolf; Benjamin Lechner; Martin Bidlingmaier; Graeme Eisenhofer; Tracy Ann Williams; Martin Reincke
Journal:  Curr Hypertens Rep       Date:  2019-09-03       Impact factor: 5.369

Review 4.  MANAGEMENT OF ENDOCRINE DISEASE: The role of surgical adrenalectomy in primary aldosteronism.

Authors:  Gregory L Hundemer; Anand Vaidya
Journal:  Eur J Endocrinol       Date:  2020-12       Impact factor: 6.664

5.  Hypertension Cure Following Laparoscopic Adrenalectomy for Hyperaldosteronism is not Universal: Trends Over Two Decades.

Authors:  Takeshi Namekawa; Takanobu Utsumi; Tomoaki Tanaka; Mayuko Kaga; Hidekazu Nagano; Takashi Kono; Koji Kawamura; Naoto Kamiya; Takashi Imamoto; Hiroyoshi Suzuki; Tomohiko Ichikawa
Journal:  World J Surg       Date:  2017-04       Impact factor: 3.352

6.  Cosyntropin stimulation in adrenal vein sampling improves the judgment of successful adrenal vein catheterization and outcome prediction for primary aldosteronism.

Authors:  Midori Yatabe; Kanako Bokuda; Kaoru Yamashita; Satoshi Morimoto; Junichi Yatabe; Yasufumi Seki; Daisuke Watanabe; Satoru Morita; Shuji Sakai; Atsuhiro Ichihara
Journal:  Hypertens Res       Date:  2020-04-30       Impact factor: 3.872

7.  Validation of the Aldosteronoma Resolution Score Within Current Clinical Practice.

Authors:  Wessel M C M Vorselaars; Dirk-Jan van Beek; Emily L Postma; Wilko Spiering; Inne H M Borel Rinkes; Gerlof D Valk; Menno R Vriens
Journal:  World J Surg       Date:  2019-10       Impact factor: 3.352

8.  Prognostic value of semiquantification NP-59 SPECT/CT in primary aldosteronism patients after adrenalectomy.

Authors:  Ching-Chu Lu; Vin-Cent Wu; Kwan-Dun Wu; Kao-Lang Liu; Wei-Chou Lin; Mei-Fang Cheng; Kai-Yuan Tzen; Ruoh-Fang Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-14       Impact factor: 9.236

9.  Adrenal histologic findings show no difference in clinical presentation and outcome in primary hyperaldosteronism.

Authors:  Allison B Weisbrod; Richard C Webb; Aarti Mathur; Stephanie Barak; Smita Baid Abraham; Naris Nilubol; Martha Quezado; Constantine A Stratakis; Electron Kebebew
Journal:  Ann Surg Oncol       Date:  2012-10-23       Impact factor: 5.344

10.  Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype.

Authors:  Ute I Scholl; James M Healy; Anne Thiel; Annabelle L Fonseca; Taylor C Brown; John W Kunstman; Matthew J Horne; Dimo Dietrich; Jasmin Riemer; Seher Kücükköylü; Esther N Reimer; Anna-Carinna Reis; Gerald Goh; Glen Kristiansen; Amit Mahajan; Reju Korah; Richard P Lifton; Manju L Prasad; Tobias Carling
Journal:  Clin Endocrinol (Oxf)       Date:  2015-09-23       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.